Filgotinib (Jyseleca)

Ingredients: Filgotinib
Dosage Form: Oral tablets
Innovator’s Brand Name: Jyseleca
Generic Brand Name: Filgotin
Generic Manufacturer: Ziska Pharma

Indications:
Filgotinib is indicated for the treatment of moderate to severe active rheumatoid arthritis (as monotherapy or in combination with methotrexate) and moderate to severe active ulcerative colitis in patients with an inadequate response to conventional therapies.

Dosage and Administration:
The recommended dose is 200 mg orally once daily; for high‑risk patients, the maintenance dose may be reduced to 100 mg once daily, with further adjustments based on clinical status.

Adverse Reactions:
Common adverse reactions include nausea, upper respiratory tract infection, urinary tract infection, and dizziness.

Storage:
Store in a cool, dry place below 25 °C, protected from light, and keep out of reach of children.

Package Insert (Prescribing Information):

Download Link